Business Description
Bluejay Diagnostics Inc
NAICS : 325413
SIC : 5047
ISIN : US0956335097
Total Employee Number:
6Description
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 37.98 | |||||
Equity-to-Asset | 0.75 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -0.01 | |||||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 88.2 | |||||
3-Year EPS without NRI Growth Rate | 89.9 | |||||
3-Year FCF Growth Rate | 88.4 | |||||
3-Year Book Growth Rate | -90.5 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 50.73 | |||||
9-Day RSI | 38.27 | |||||
14-Day RSI | 38.07 | |||||
3-1 Month Momentum % | 122 | |||||
6-1 Month Momentum % | 57.8 | |||||
12-1 Month Momentum % | -31.06 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.81 | |||||
Quick Ratio | 2.81 | |||||
Cash Ratio | 2.61 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -745.8 | |||||
Shareholder Yield % | -255.81 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -150.05 | |||||
ROA % | -117.86 | |||||
ROIC % | -393.65 | |||||
3-Year ROIIC % | -1321.23 | |||||
ROC (Joel Greenblatt) % | -427.23 | |||||
ROCE % | -148.87 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 0.36 | |||||
Price-to-Tangible-Book | 0.36 | |||||
EV-to-EBIT | 0.3 | |||||
EV-to-EBITDA | 0.31 | |||||
EV-to-FCF | 0.32 | |||||
| Price-to-Net-Current-Asset-Value | 0.59 | |||||
| Price-to-Net-Cash | 0.66 | |||||
Earnings Yield (Greenblatt) % | 333.33 | |||||
FCF Yield % | -431.8 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:BJDX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bluejay Diagnostics Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -13.995 | ||
| Beta | 0.9367 | ||
| 3-Year Sharpe Ratio | -1.97 | ||
| 3-Year Sortino Ratio | -1.85 | ||
| Volatility % | 100.58 | ||
| 14-Day RSI | 38.07 | ||
| 14-Day ATR ($) | 0.45214 | ||
| 20-Day SMA ($) | 1.989 | ||
| 12-1 Month Momentum % | -31.06 | ||
| 52-Week Range ($) | 1.03 - 16.68 | ||
| Shares Outstanding (Mil) | 1.03 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bluejay Diagnostics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bluejay Diagnostics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-06 | In 109 days | ||
| Second quarter earnings results for 2026 | 2026-08-07 | In 18 days | ||
| General meeting for 2025 | 2026-06-18 13:00 | 4.44 (+0.91%) | ||
| General meeting for 2026 | 2026-06-09 13:00 | 5.23 (+4.81%) | ||
| First quarter earnings results for 2026 | 2026-05-07 | 1.89 (-2.07%) | ||
| Annual report for 2025 | 2026-03-06 | 1.90 (+1.06%) | ||
| 0.25:1 Stock Split | 2026-01-29 | 3.25 (+6.78%) | ||
| Third quarter earnings results for 2025 | 2025-11-07 | 6.36 (-8.09%) | ||
| Second quarter earnings results for 2025 | 2025-08-07 | 5.88 (-3.29%) | ||
| General meeting for 2024 | 2025-06-18 13:00 | 6.52 (-1.21%) |
Show
Entries
Bluejay Diagnostics Inc Frequently Asked Questions
What is Bluejay Diagnostics Inc(BJDX)'s stock price today?
The current price of BJDX is $1.45. The 52 week high of BJDX is $16.68 and 52 week low is $1.03.
When is next earnings date of Bluejay Diagnostics Inc(BJDX)?
The next earnings date of Bluejay Diagnostics Inc(BJDX) is 2026-08-07 Est..
Does Bluejay Diagnostics Inc(BJDX) pay dividends? If so, how much?
Bluejay Diagnostics Inc(BJDX) does not pay dividend.
Guru Commentaries on NAS:BJDX
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Bluejay Diagnostics Inc
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers